Related Experiment Video
Updated: Mar 14, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
TRIM5α Resistance Escape Mutations in the Capsid Are Transferable between Simian Immunodeficiency Virus Strains
Fan Wu1, Andrea Kirmaier2, Ellen White3
1Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA wuf2@niaid.nih.gov vhirsch@niaid.nih.gov.
Abstract:
TRIM5α polymorphism limits and complicates the use of simian immunodeficiency virus (SIV) for evaluation of human immunodeficiency virus (HIV) vaccine strategies in rhesus macaques. We previously reported that the TRIM5α-sensitive SIV from sooty mangabeys (SIVsm) clone SIVsmE543-3 acquired amino acid substitutions in the capsid that overcame TRIM5α restriction when it was passaged in rhesus macaques expressing restrictive TRIM5α alleles. Here we generated TRIM5α-resistant clones of the related SIVsmE660 strain without animal passage by introducing the same amino acid capsid substitutions. We evaluated one of the variants in rhesus macaques expressing permissive and restrictive TRIM5α alleles. The SIVsmE660 variant infected and replicated in macaques with restrictive TRIM5α genotypes as efficiently as in macaques with permissive TRIM5α genotypes. These results demonstrated that mutations in the SIV capsid can confer SIV resistance to TRIM5α restriction without animal passage, suggesting an applicable method to generate more diverse SIV strains for HIV vaccine studies.
Importance:
Many strains of SIV from sooty mangabey monkeys are susceptible to resistance by common rhesus macaque TRIM5α alleles and result in reduced virus acquisition and replication in macaques that express these restrictive alleles. We previously observed that spontaneous variations in the capsid gene were associated with improved replication in macaques, and the introduction of two amino acid changes in the capsid transfers this improved replication to the parent clone. In the present study, we introduced these mutations into a related but distinct strain of SIV that is commonly used for challenge studies for vaccine trials. These mutations also improved the replication of this strain in macaques with the restrictive TRIM5α genotype and thus will eliminate the confounding effects of TRIM5α in vaccine studies.
Insights
Simian immunodeficiency virus (SIV) capsid mutations can overcome rhesus macaque TRIM5α restriction, improving SIV replication. This advance enables more reliable simian immunodeficiency virus (SIV) studies for human immunodeficiency virus (HIV) vaccine development.
Area of Science:
- Virology and Immunology
- Vaccine Development
- Primate Models
Background:
- Polymorphisms in TRIM5α (TRIM-cotransporter factor 5 alpha) present a significant barrier in using simian immunodeficiency virus (SIV) for human immunodeficiency virus (HIV) vaccine research in rhesus macaques.
- Common rhesus macaque TRIM5α alleles restrict SIV acquisition and replication, complicating vaccine efficacy studies.
- Previous work identified capsid gene variations conferring TRIM5α resistance and improved SIV replication in macaques.
Purpose of the Study:
- To engineer TRIM5α-resistant simian immunodeficiency virus (SIV) strains without requiring animal passage.
- To evaluate the efficacy of TRIM5α-resistant SIV variants in rhesus macaques with varying TRIM5α genotypes.
- To provide a method for generating diverse SIV strains to mitigate TRIM5α restriction in HIV vaccine studies.
Main Methods:
- Introduction of specific amino acid substitutions into the capsid gene of the SIVsmE660 strain to confer TRIM5α resistance.
- Generation of TRIM5α-resistant SIV variants in vitro, bypassing the need for animal passage.
- Infection and replication assessment of a selected SIVsmE660 variant in rhesus macaques possessing both permissive and restrictive TRIM5α alleles.
Main Results:
- Engineered SIVsmE660 variants demonstrated resistance to TRIM5α restriction in vitro.
- The SIVsmE660 variant efficiently infected and replicated in rhesus macaques with restrictive TRIM5α genotypes.
- Replication levels in macaques with restrictive TRIM5α were comparable to those with permissive TRIM5α genotypes.
Conclusions:
- Mutations within the SIV capsid can effectively confer resistance to TRIM5α restriction without necessitating animal passage.
- This strategy offers a viable approach to create diverse SIV strains for more robust HIV vaccine evaluations.
- Overcoming TRIM5α restriction enhances the utility of SIV in rhesus macaque models for advancing HIV vaccine development.
More Related Videos
Related Concept Videos
Viral Mutations
Retroviruses

